RESUMEN
This paper presents a modular software design for the construction of computational modeling technology that will help implement precision medicine. In analogy to a common industrial strategy used for preventive maintenance of engineered products, medical digital twins are computational models of disease processes calibrated to individual patients using multiple heterogeneous data streams. They have the potential to help improve diagnosis, prognosis, and personalized treatment for a wide range of medical conditions. Their large-scale development relies on both mechanistic and data-driven techniques and requires the integration and ongoing update of multiple component models developed across many different laboratories. Distributed model building and integration requires an open-source modular software platform for the integration and simulation of models that is scalable and supports a decentralized, community-based model building process. This paper presents such a platform, including a case study in an animal model of a respiratory fungal infection.
Asunto(s)
Aspergilosis/tratamiento farmacológico , Biología Computacional/métodos , Modelación Específica para el Paciente , Medicina de Precisión/métodos , Programas Informáticos , Algoritmos , Animales , Antifúngicos/farmacología , Aspergilosis/microbiología , Aspergilosis/patología , Aspergillus fumigatus/crecimiento & desarrollo , Aspergillus fumigatus/patogenicidad , Humanos , Esporas Fúngicas/crecimiento & desarrollo , Esporas Fúngicas/patogenicidadRESUMEN
Medical digital twins, which are potentially vital for personalized medicine, have become a recent focus in medical research. Here we present an overview of the state of the art in medical digital twin development, especially in oncology and cardiology, where it is most advanced. We discuss major challenges, such as data integration and privacy, and provide an outlook on future advancements. Emphasizing the importance of this technology in healthcare, we highlight the potential for substantial improvements in patient-specific treatments and diagnostics.
Asunto(s)
Investigación Biomédica , Cardiología , Humanos , Medicina de Precisión , Instituciones de Salud , Oncología MédicaRESUMEN
Tumor necrosis factor alpha (TNF) has been shown to be an essential cytokine mediator of innate immunity in bacterial pneumonia. To augment the expression of TNF within the lung, a recombinant adenoviral vector containing the murine TNF cDNA (Ad5mTNF) has been developed, and the intratracheal administration of this vector resulted in the dose- and time-dependent expression of TNF in the lung, but not systemically. Administration of Ad5mTNF resulted in significant airspace and peribronchial inflammation, with a predominant neutrophil influx by 2 days, and mononuclear cell infiltrates by 4 to 7 days posttreatment. Importantly, the administration of Ad5mTNF at a dose of 1 x 10(8) PFU significantly improved the survival of animals challenged concomitantly with Klebsiella pneumoniae, which occurred in association with enhanced clearance of bacteria from the lung and decreased dissemination of K. pneumoniae to the bloodstream. However, the delivery of higher doses of Ad5mTNF (5 x 10(8) PFU) was not beneficial and in fact the intratracheal administration of a similar dose of control vector (Ad5LacZ) actually enhanced Klebsiella-induced lethality by impairing clearance of K. pneumoniae from the lung. Our studies suggests that the transient transgenic expression of TNF within the lung dose dependently augments antibacterial host defense in murine Klebsiella pneumonia.
Asunto(s)
Terapia Genética , Klebsiella pneumoniae/aislamiento & purificación , Neumonía Bacteriana/terapia , Factor de Necrosis Tumoral alfa/genética , Adenoviridae/genética , Animales , Líquido del Lavado Bronquioalveolar , ADN Complementario , Femenino , Vectores Genéticos , Inmunohistoquímica , Pulmón/metabolismo , Ratones , Ratones Endogámicos CBA , Neumonía Bacteriana/microbiología , Tasa de Supervivencia , TransgenesRESUMEN
Host defense of the lung is characterized by a fine balance between the generation of a vigorous inflammatory response to clear pathogens and maintenance of the integrity of the alveolar gas-exchange surface. The magnitude of the inflammatory response is therefore tightly regulated by pro- and anti-inflammatory cytokine mediators. This article summarizes current information on the roles of specific cytokines in pneumonia, with particular emphasis on ongoing investigations into the role of innate immunity in bacterial and fungal pneumonia.
Asunto(s)
Citocinas/inmunología , Neumonía/inmunología , Citocinas/clasificación , Citocinas/uso terapéutico , Humanos , Inmunidad Innata , Enfermedades Pulmonares Fúngicas/inmunología , Macrófagos/inmunología , Monocitos/inmunología , Neutrófilos/inmunología , Neumonía Bacteriana/inmunologíaRESUMEN
STUDY OBJECTIVES: (1) To define the incidence and natural history of Aspergillus colonization and infection in lung transplant recipients, and (2) to assess the impact of prophylaxis, surveillance, and therapy on the incidence and outcome of the disease. DESIGN: Retrospective review of 133 consecutive single or bilateral lung transplantations performed at a single institution, and review of the published literature. RESULTS: Airway colonization, isolated tracheobronchitis, and invasive pneumonia due to Aspergillus species occurred in 29%, 5%, and 8% of our series, and in 26%, 4%, and 5% of the pooled published data (all series, including ours), respectively. Greater than 50% of all diagnoses were made in the first 6 months after transplantation in both our series and the published literature. Incidence of progression from airway colonization to invasive disease was 1 in 38 in our series and 3 of 97 (3%) in the pooled published data. In patients with isolated tracheobronchitis, all 6 patients in our series and 41 of 50 patients (82%) in all published series, including ours, responded to antifungal therapy and/or surgical debridement. Among patients with invasive pneumonia or disseminated disease, however, 5 of 10 patients in our series and 26 of 64 patients (41%) in the pooled series survived their infection. CONCLUSIONS: The role of antifungal therapy in Aspergillus airway colonization in lung transplant recipients is unclear. Data support a strategy of scheduled screening bronchoscopy followed by aggressive treatment for isolated Aspergillus tracheobronchitis in lung transplant recipients.
Asunto(s)
Aspergilosis/diagnóstico , Enfermedades Pulmonares Fúngicas/diagnóstico , Trasplante de Pulmón , Infecciones Oportunistas/diagnóstico , Complicaciones Posoperatorias/diagnóstico , Adolescente , Adulto , Aspergilosis/epidemiología , Bronquitis/diagnóstico , Bronquitis/epidemiología , Broncoscopía , Estudios Transversales , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Enfermedades Pulmonares Fúngicas/epidemiología , Masculino , Michigan , Persona de Mediana Edad , Infecciones Oportunistas/epidemiología , Complicaciones Posoperatorias/epidemiología , Factores de RiesgoRESUMEN
Neuroimaging findings in cases of St. Louis encephalitis (StLE) have yet to be reported despite the relatively high frequency of this entity. An epidemic permitted the documentation of isolated hyperintensity of the substantia nigra on T2-weighted images in two patients with StLE. This distribution of MR imaging abnormality in cases of StLE mirrors the reports presented in the literature that implicate the substantia nigra as peculiarly susceptible to the StLE virus. Isolated lesions of the substantia nigra revealed by T2-weighted imaging should suggest the possibility of StLE.
Asunto(s)
Encefalitis de San Luis/diagnóstico , Imagen por Resonancia Magnética , Sustancia Negra/patología , Adulto , Humanos , MasculinoRESUMEN
Many aspects of antimicrobial host responses are orchestrated by a complex network of cytokines and their receptors. This review focuses on recent progress in our understanding of the function of cytokines in innate immune responses to Aspergillus. TNF, a recognition cytokine, has been shown to be required for initiation of the innate response in the mouse model of invasive aspergillosis. Several recruitment cytokines play critical roles in mediating influx of specific leukocytes to the site of infection in invasive aspergillosis. Among these, the ELR + subset of CXC chemokines and their receptor CXCR2 are critical to neutrophil recruitment, while CCL3/macrophage inflammatory protein (MIP)-1alpha and CCL2/ monocyte chemoattractant protein (MCP)-1 are critical to recruitment of monocyte-lineage leukocytes and NK cells, respectively. Of the activation cytokines, those associated with the Th-1 phenotype, including interleukin (IL)-12, IL-18, and interferon-gamma (IFN-gamma), are critical to protective responses to the infection. Conversely, the Th2-phenotype cytokines IL-4 and IL-10 contribute to progression of infection. Modulation of the immune response to Aspergillus by manipulating these mediators remains intriguing as a potential adjunctive treatment in patients with invasive aspergillosis.
Asunto(s)
Aspergilosis/inmunología , Aspergillus/inmunología , Citocinas/metabolismo , Inmunidad Innata , Animales , Aspergilosis/microbiología , Humanos , RatonesRESUMEN
Invasive pulmonary aspergillosis is a devastating complication of immunosuppression that usually occurs in neutropenic patients. In this setting, augmentation of the antifungal activity of available immune cells may improve the outcome of the infection. Macrophage inflammatory protein-1 alpha (MIP-1 alpha) is a CC chemokine with potent chemotactic activity for various subsets of mononuclear leukocytes. We therefore tested the hypothesis that the influx of mononuclear cells into the lung in invasive pulmonary aspergillosis is in part mediated by MIP-1 alpha, and the manipulation of this ligand alters the outcome of the infection. We found that in both immunocompetent and neutropenic mice, MIP-1 alpha was induced in the lungs in response to intratracheal administration of Aspergillus fumigatus conidia. In neutrophil-depleted mice challenged with intratracheal conidia, there was evidence of invasive fungal pneumonia associated with a predominantly mononuclear leukocyte infiltrate. Ab-mediated depletion of MIP-1 alpha resulted in a 6-fold increase in mortality in neutropenic mice, which was associated with a 12-fold increase in lung fungal burden. Studies of single-cell suspensions of whole lungs revealed a 36% decrease in total lung leukocyte infiltration as a result of MIP-1 alpha neutralization. Flow cytometry on whole lung suspensions showed a 41% reduction in lung monocyte/macrophages as a result of MIP-1 alpha neutralization, but no difference in other lung leukocyte subsets. These studies indicate that MIP-1 alpha is a critical mediator of host defense against A. fumigatus in the setting of neutropenia and may be an important target in devising future therapeutic strategies against invasive aspergillosis.
Asunto(s)
Aspergilosis/inmunología , Enfermedades Pulmonares Fúngicas/inmunología , Proteínas Inflamatorias de Macrófagos/fisiología , Neutropenia/inmunología , Animales , Aspergilosis/microbiología , Aspergilosis/prevención & control , Aspergillus fumigatus/inmunología , Movimiento Celular/inmunología , Quimiocina CCL4 , Femenino , Sueros Inmunes/administración & dosificación , Inmunidad Innata/inmunología , Inyecciones Intradérmicas , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/microbiología , Pulmón/inmunología , Pulmón/metabolismo , Pulmón/microbiología , Enfermedades Pulmonares Fúngicas/prevención & control , Proteínas Inflamatorias de Macrófagos/antagonistas & inhibidores , Proteínas Inflamatorias de Macrófagos/biosíntesis , Proteínas Inflamatorias de Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Desnudos , Neutropenia/etiología , Neutropenia/microbiología , Neutrófilos/inmunologíaRESUMEN
Invasive pulmonary aspergillosis is a common and devastating complication of immunosuppression, whose incidence has increased dramatically in tandem with the increase in the number of immunocompromised patients. Given the role of TNF-alpha in other pulmonary infections, we hypothesized that TNF-alpha is an important proximal signal in murine invasive pulmonary aspergillosis. Intratracheal challenge with Aspergillus fumigatus conidia in both neutropenic (cyclophosphamide-treated) and nonneutropenic BALB/c mice resulted in the time-dependent increase in lung TNF-alpha levels, which correlated with the histologic development of a patchy, peribronchial infiltration of mononuclear and polymorphonuclear cells. Ab-mediated neutralization of TNF-alpha resulted in an increase in mortality in both normal and cyclophosphamide-treated animals, which was associated with increased lung fungal burden as determined by histology and as quantified by chitin content. Depletion of TNF-alpha resulted in a reduced lung neutrophil influx in both normal and cyclophosphamide-treated animals, which occurred in association with a decrease in lung levels of the C-X-C chemokine, macrophage inflammatory protein-2 and the C-C chemokines macrophage inflammatory protein-1alpha and JE. In cyclophosphamide-treated animals, intratracheal administration of a TNF-alpha agonist peptide (TNF70-80) 3 days before, but not concomitant with, the administration of Aspergillus conidia resulted in improved survival from 9% in control mice to 55% in TNF70-80-treated animals. These studies indicate that TNF-alpha is a critical component of innate immunity in both immunocompromised and immunocompetent hosts, and that pretreatment with a TNF-alpha agonist peptide in a compartmentalized fashion can significantly enhance resistance to A. fumigatus in neutropenic animals.
Asunto(s)
Aspergilosis/inmunología , Aspergillus fumigatus , Enfermedades Pulmonares Fúngicas/inmunología , Pulmón/inmunología , Factor de Necrosis Tumoral alfa/inmunología , Animales , Anticuerpos/farmacología , Aspergilosis/etiología , Aspergilosis/patología , Quimiocinas CC/metabolismo , Quimiocinas CXC/metabolismo , Ciclofosfamida/farmacología , Femenino , Huésped Inmunocomprometido , Inmunosupresores/farmacología , Pulmón/patología , Enfermedades Pulmonares Fúngicas/etiología , Enfermedades Pulmonares Fúngicas/patología , Ratones , Ratones Endogámicos BALB C , Pruebas de Neutralización , Neutropenia/complicaciones , Neutropenia/inmunología , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/inmunología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
The generation of a vigorous inflammatory response is essential for the rapid clearance of microbes from the alveolar space. The magnitude of the inflammatory response is tightly controlled by host-derived cytokines, which mediate lung inflammation by serving as leukocyte chemoattractants, leukocyte activating factors, or afferent signals in the induction or regulation of other effector molecules. In this article the role of specific cytokines in lung innate immunity will be reviewed. Future directions regarding the use of specific forms of immunotherapy, including compartmentalized cytokine delivery with gene therapy as adjuvant therapy in the treatment of pneumonia, will be explored.
Asunto(s)
Citocinas/inmunología , Inmunoterapia , Neumonía Bacteriana/terapia , Animales , Humanos , Neumonía Bacteriana/inmunologíaRESUMEN
Survival from murine pulmonary nocardiosis is highly dependent on CXC chemokine receptor-2 (CXCR2) ligand-mediated neutrophil chemotaxis and subsequent clearance of the infectious agent Nocardia asteroides. Intratracheal inoculation of N. asteroides rapidly up-regulated the CXC chemokines macrophage inflammatory protein-2 (MIP-2) and KC within 24 h, with levels remaining elevated through day 3 before returning to near baseline levels by day 7. Coinciding with elevated MIP-2 and KC were the rapid recruitment of neutrophils and clearance of the organism. Anti-Ly-6G Ab-mediated neutrophil depletion before bacterial challenge resulted in strikingly increased mortality to N. asteroides infection. The relative contribution of MIP-2 in neutrophil recruitment was examined by anti-MIP-2 Ab treatment before nocardial infection. MIP-2 neutralization had no detrimental effects on survival, neutrophil recruitment, or bacterial clearance, suggesting the usage of additional or alternative CXCR2-binding ligands. The importance of the CXC family of chemokines was determined by the administration of an anti-CXCR2 Ab capable of blocking ligand binding in vivo. Anti-CXCR2 treatment greatly increased mortality by preventing neutrophil migration into the lung. Paralleling this impaired neutrophil recruitment was a 100-fold increase in lung bacterial burden. Combined, these observations indicate a critical role for neutrophils and CXC chemokines during nocardial pneumonia. These data directly link CXCR2 ligands and neutrophil recruitment and lend further support to the concept of CXC chemokine redundancy. For infections highly dependent on neutrophils, such as nocardial pneumonia, this is of critical importance.
Asunto(s)
Nocardiosis/inmunología , Nocardiosis/microbiología , Nocardia asteroides/inmunología , Neumonía Bacteriana/inmunología , Neumonía Bacteriana/microbiología , Receptores de Quimiocina/metabolismo , Receptores de Interleucina/metabolismo , Secuencia de Aminoácidos , Animales , Antígenos Ly/inmunología , Quimiocina CXCL1 , Quimiocina CXCL2 , Quimiocinas/biosíntesis , Quimiocinas CXC , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Relación Dosis-Respuesta Inmunológica , Femenino , Sueros Inmunes/administración & dosificación , Inyecciones Intraperitoneales , Intubación Intratraqueal , Cinética , Ligandos , Pulmón/inmunología , Pulmón/metabolismo , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Monocinas/biosíntesis , Neutropenia/inmunología , Neutropenia/microbiología , Infiltración Neutrófila , Nocardiosis/mortalidad , Nocardiosis/patología , Neumonía Bacteriana/mortalidad , Neumonía Bacteriana/patología , Receptores de Quimiocina/inmunología , Receptores de Quimiocina/fisiología , Receptores de Interleucina/inmunología , Receptores de Interleucina/fisiología , Receptores de Interleucina-8BRESUMEN
Pulmonary infection due to Pseudomonas aeruginosa has emerged as a leading cause of mortality. A vigorous host response is required to effectively clear the organisms from the lungs. This host defense is dependent on the recruitment and activation of neutrophils and macrophages. A family of chemotactic cytokines (chemokines) has been shown to participate in this protective response. In this study, we assessed the role of the ELR(+) (glutamic acid-leucine-arginine motif positive) CXC chemokines and their CXC chemokine receptor (CXCR2) in lung antibacterial host defense. The intratracheal administration of Pseudomonas to mice resulted in the time-dependent influx of neutrophils to the lung, peaking at 12 to 24 h after inoculation. The influx of neutrophils was associated with a similar time-dependent expression of the ELR(+) CXC chemokines, KC, macrophage inflammatory protein 2 (MIP-2), and lipopolysaccharide-induced CXC chemokine (LIX). Selective neutralization of MIP-2 or KC resulted in modest changes in neutrophil influx but no change in bacterial clearance or survival. However, neutralization of CXCR2 resulted in a striking increase in mortality, which was associated with a marked decrease in neutrophil recruitment and bacterial clearance. Conversely, the site-specific transgenic expression of KC resulted in enhanced clearance of bacteria after Pseudomonas challenge. This study indicates that ELR(+) CXC chemokines are critical mediators of neutrophil-mediated host defense in Pseudomonas pneumonia.
Asunto(s)
Neumonía Bacteriana/inmunología , Infecciones por Pseudomonas/inmunología , Pseudomonas aeruginosa/inmunología , Receptores de Quimiocina/metabolismo , Receptores de Interleucina/metabolismo , Animales , Secuencia de Bases , Quimiocinas CXC/biosíntesis , Quimiocinas CXC/genética , Citocinas/biosíntesis , Citocinas/genética , Cartilla de ADN/genética , Femenino , Humanos , Pulmón/inmunología , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Endogámicos C57BL , Pruebas de Neutralización , Neutrófilos/inmunología , Neumonía Bacteriana/genética , Neumonía Bacteriana/patología , Infecciones por Pseudomonas/genética , Infecciones por Pseudomonas/patología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Quimiocina/antagonistas & inhibidores , Receptores de Interleucina/antagonistas & inhibidores , Receptores de Interleucina-8BRESUMEN
Invasive pulmonary aspergillosis is a devastating complication of immunosuppression, which occurs in association with neutrophil dysfunction or deficiency. ELR+ CXC chemokines are a subfamily of chemokines that play a critical role in neutrophil chemotaxis and activation both in vitro and in vivo. We hypothesized that interaction of these ligands with CXC chemokine receptor-2 (CXCR2), their sole murine receptor, is a major component of neutrophil-dependent pulmonary host defense against Aspergillus fumigatus. In immunocompetent animals, neutrophils were recruited to the lung in response to intratracheally administered A. fumigatus conidia. In a model of transient in vivo depletion of neutrophils, animals developed invasive pulmonary aspergillosis, associated with delayed influx of neutrophils into the lung. In both normal and neutrophil-depleted animals, the ELR+ CXC chemokines MIP-2 and KC were induced in response to intratracheal administration of conidia. Ab-mediated neutralization of the common ELR+ CXC chemokine receptor, CXCR2, resulted in development of invasive disease indistinguishable from the disease in neutrophil-depleted animals, while control animals were highly resistant to the development of infection. CXCR2 neutralization was associated with reduced lung neutrophil influx and resulted in a marked increase in mortality compared with controls. In contrast, animals with constitutive lung-specific transgenic expression of KC were resistant to the organism, with reduced mortality and lower lung burden of fungus. We conclude that CXCR2 ligands are essential mediators of host defense against A. fumigatus, and may be important targets in devising future therapeutic strategies in this disease.
Asunto(s)
Aspergilosis/inmunología , Quimiocinas CXC/metabolismo , Péptidos y Proteínas de Señalización Intercelular , Enfermedades Pulmonares Fúngicas/inmunología , Neutrófilos/inmunología , Receptores de Quimiocina/metabolismo , Receptores de Interleucina/metabolismo , Animales , Aspergilosis/mortalidad , Quimiocina CXCL1 , Quimiocina CXCL2 , Factores Quimiotácticos/metabolismo , Quimiotaxis de Leucocito , Femenino , Sustancias de Crecimiento/metabolismo , Terapia de Inmunosupresión , Ligandos , Pulmón/patología , Enfermedades Pulmonares Fúngicas/mortalidad , Ratones , Ratones Endogámicos C57BL , Monocinas/metabolismo , Infiltración Neutrófila , Receptores de Interleucina-8BRESUMEN
Asperigillus fumigatus spores or conidia are quickly eliminated from the airways of nonsensitized individuals but persist in individuals with allergic pulmonary responsiveness to fungus. A. fumigatus-induced allergic airway disease is characterized by persistent airway hyperreactivity, inflammation, and fibrosis. The present study explored the role of CCR2 ligands in the murine airway response to A. fumigatus conidia. Nonsensitized and A. fumigatus-sensitized CBA/J mice received an intratracheal challenge of A. fumigatus conidia, and pulmonary changes were analyzed at various times after conidia. Whole lung levels of monocyte chemoattractant protein-1 (MCP-1/CCL2), but neither MCP-3/CCL7 nor MCP-5/CCL12, were significantly elevated at days 3 and 7 after conidia in nonsensitized mice. MCP-1/CCL2 was significantly increased in lung samples from A. fumigatus-sensitized mice at days 14 and 30 after a conidia challenge. Administration of anti-MCP-1/CCL2 antiserum to nonsensitized mice for14 days after the conidia challenge attenuated the clearance of conidia and significantly increased airway hyperreactivity, eosinophilia, and peribronchial fibrosis compared with nonsensitized mice that received conidia and normal serum. Adenovirus-directed overexpression of MCP-1/CCL2 in A. fumigatus-sensitized mice markedly reduced the number of conidia, airway inflammation, and airway hyperresponsiveness at day 7 after the conidia challenge in these mice. Immunoneutralization of MCP-1/CCL2 levels in A. fumigatus-sensitized mice during days14-30 after the conidia challenge did not affect the conidia burden but significantly reduced airway hyperreactivity, lung IL-4 levels, and lymphocyte recruitment into the airways compared with the control group. These data suggest that MCP-1/CCL2 participates in the pulmonary antifungal and allergic responses to A. fumigatus conidia.
Asunto(s)
Antifúngicos/farmacología , Aspergilosis Broncopulmonar Alérgica/inmunología , Aspergilosis Broncopulmonar Alérgica/patología , Aspergillus fumigatus/inmunología , Quimiocina CCL2/fisiología , Adenoviridae/genética , Adyuvantes Inmunológicos/fisiología , Animales , Antígenos Fúngicos/administración & dosificación , Antígenos Fúngicos/inmunología , Aspergilosis Broncopulmonar Alérgica/microbiología , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/microbiología , Movimiento Celular/inmunología , Quimiocina CCL2/antagonistas & inhibidores , Quimiocina CCL2/biosíntesis , Quimiocina CCL2/inmunología , Eosinófilos/inmunología , Femenino , Fibrosis , Sueros Inmunes/administración & dosificación , Inyecciones Intraperitoneales , Intubación Intratraqueal , Pulmón/inmunología , Pulmón/microbiología , Pulmón/patología , Ratones , Ratones Endogámicos CBA , Esporas Fúngicas/inmunologíaRESUMEN
Clinical allergic airway disease is associated with persistent airway hyperreactivity and remodeling, but little is known about the mechanisms leading to these alterations. This paucity of information is related in part to the absence of chronic models of allergic airway disease. Herein we describe a model of persistent airway hyperreactivity, goblet cell hyperplasia, and subepithelial fibrosis that is initiated by the intratracheal introduction of Aspergillus fumigatus spores or conidia into the airways of mice previously sensitized to A. fumigatus. Similar persistent airway alterations were not observed in nonsensitized mice challenged with A. fumigatus conidia alone. A. fumigatus-sensitized mice exhibited significantly enhanced airway hyperresponsiveness to a methacholine challenge that was still present at 30 days after the conidia challenge. Eosinophils and lymphocytes were present in bronchoalveolar lavage (BAL) samples from A. fumigatus-sensitized mice at all times after conidia challenge. Compared with levels measured in A. fumigatus-sensitized mice immediately before conidia, significantly elevated interferon-gamma (IFN-gamma) and transforming growth factor (TGF-beta) levels were present in whole lung homogenates up to 7 days after the conidia challenge. At day 30 after conidia challenge, significantly elevated levels of interleukin-4 (IL-4) and IL-13 were present in the A. fumigatus-sensitized mice. Histological analysis revealed profound goblet cell hyperplasia and airway fibrosis at days 30 after conidia, and the latter finding was confirmed by hydroxyproline measurements. Thus the introduction of A. fumigatus conidia into A. fumigatus-sensitized mice results in persistent airway hyperresponsiveness, fibrosis, and goblet cell hyperplasia.
Asunto(s)
Aspergillus fumigatus/inmunología , Bronquios/patología , Hiperreactividad Bronquial/etiología , Células Caliciformes/patología , Hipersensibilidad/complicaciones , Hipersensibilidad/patología , Animales , Líquido del Lavado Bronquioalveolar/citología , Enfermedad Crónica , Citocinas/metabolismo , Eosinófilos/patología , Femenino , Fibrosis , Hiperplasia , Inmunización , Inmunoglobulina E/sangre , Pulmón/metabolismo , Linfocitos/patología , Ratones , Ratones Endogámicos CBARESUMEN
Asthmatic-like reactions characterized by elevated IgE, Th2 cytokines, C-C chemokines, eosinophilic inflammation, and persistent airway hyperresponsiveness follow pulmonary exposure to the spores or conidia from Aspergillus fumigatus fungus in sensitized individuals. In addition to these features, subepithelial fibrosis and goblet cell hyperplasia characterizes fungal-induced allergic airway disease in mice. Because lung concentrations of macrophage inflammatory protein-1alpha and RANTES were significantly elevated after A. fumigatus-sensitized mice received an intrapulmonary challenge with A. fumigatus spores or conidia, the present study addressed the role of their receptor, C-C chemokine receptor 1 (CCR1), in this model. A. fumigatus-sensitized CCR1 wild-type (+/+) and CCR1 knockout (-/-) mice exhibited similar increases in serum IgE and polymorphonuclear leukocyte numbers in the bronchoalveolar lavage. Airway hyperresponsiveness was prominent in both groups of mice at 30 days after an intrapulmonary challenge with A. fumigatus spores or conidia. However, whole lung levels of IFN-gamma were significantly higher whereas IL-4, IL-13, and Th2-inducible chemokines such as C10, eotaxin, and macrophage-derived chemokine were significantly lower in whole lung samples from CCR1-/- mice compared with CCR1+/+ mice at 30 days after the conidia challenge. Likewise, significantly fewer goblet cells and less subepithelial fibrosis were observed around large airways in CCR1-/- mice at the same time after the conidia challenge. Thus, these findings demonstrate that CCR1 is a major contributor to the airway remodeling responses that arise from A. fumigatus-induced allergic airway disease.
Asunto(s)
Aspergilosis Broncopulmonar Alérgica/inmunología , Aspergilosis Broncopulmonar Alérgica/patología , Receptores de Quimiocina/deficiencia , Receptores de Quimiocina/genética , Animales , Aspergilosis Broncopulmonar Alérgica/genética , Aspergilosis Broncopulmonar Alérgica/microbiología , Aspergillus fumigatus/inmunología , Hiperreactividad Bronquial/etiología , Hiperreactividad Bronquial/inmunología , Hiperreactividad Bronquial/microbiología , Hiperreactividad Bronquial/patología , Líquido del Lavado Bronquioalveolar/inmunología , Movimiento Celular/inmunología , Quimiocina CCL4 , Quimiocina CCL5/metabolismo , Quimiocinas/biosíntesis , Enfermedad Crónica , Citocinas/metabolismo , Citocinas/fisiología , Inmunoglobulina E/sangre , Interferón gamma/metabolismo , Pulmón/química , Pulmón/inmunología , Pulmón/metabolismo , Pulmón/patología , Recuento de Linfocitos , Proteínas Inflamatorias de Macrófagos/metabolismo , Macrófagos Alveolares/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , ARN Mensajero/biosíntesis , Receptores CCR1 , Receptores de Quimiocina/agonistas , Receptores de Quimiocina/biosíntesis , Esporas Fúngicas/inmunología , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
Allergic responses to Aspergillus species exacerbate asthma and cystic fibrosis. The natural defense against live Aspergillus fumigatus spores or conidia depends on the recruitment and activation of mononuclear and polymorphonuclear leukocytes, events that are dependent on chemotactic cytokines. In this study, we explored the relative contribution of the monocyte chemoattractant protein-1 receptor, CCR2, in the pulmonary response to A. fumigatus conidia. Following sensitization to soluble A. fumigatus Ags, mice lacking CCR2 due to targeted deletion were markedly more susceptible to the injurious effects of an intrapulmonary challenge with live conidia compared with mice that expressed CCR2 or CCR2+/+. CCR2-/- mice exhibited a major defect in the recruitment of polymorphonuclear cells, but these mice also had significantly more eosinophils and lymphocytes in bronchoalveolar lavage samples. CCR2-/- mice also had significant increases in serum levels of total IgE and whole lung levels of IL-5, IL-13, eotaxin, and RANTES compared with CCR2+/+ mice. Airway inflammation, hyper-responsiveness to spasmogens, and subepithelial fibrosis were significantly enhanced in CCR2-/- mice compared with CCR2+/+ mice after the conidia challenge. Thus, these findings demonstrate that CCR2 plays an important role in the immune response against A. fumigatus, thereby limiting the allergic airway inflammatory and remodeling responses to this fungus.
Asunto(s)
Aspergilosis Broncopulmonar Alérgica/genética , Aspergilosis Broncopulmonar Alérgica/inmunología , Aspergillus fumigatus/inmunología , Receptores de Quimiocina/deficiencia , Receptores de Quimiocina/genética , Animales , Antígenos Fúngicos/administración & dosificación , Antígenos Fúngicos/inmunología , Aspergilosis Broncopulmonar Alérgica/microbiología , Aspergilosis Broncopulmonar Alérgica/patología , Hiperreactividad Bronquial/genética , Hiperreactividad Bronquial/inmunología , Movimiento Celular/inmunología , Quimiocina CCL11 , Quimiocina CCL2/agonistas , Quimiocina CCL22 , Quimiocina CCL5/biosíntesis , Quimiocina CCL7 , Quimiocinas CC/biosíntesis , Citocinas/biosíntesis , Eosinófilos/inmunología , Eosinófilos/patología , Fibrosis , Huésped Inmunocomprometido/genética , Inmunoglobulina E/sangre , Inyecciones Intraperitoneales , Inyecciones Subcutáneas , Interleucina-13/biosíntesis , Interleucina-5/biosíntesis , Pulmón/inmunología , Pulmón/metabolismo , Pulmón/microbiología , Pulmón/patología , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Proteínas Quimioatrayentes de Monocitos/agonistas , Neutrófilos/inmunología , Neutrófilos/patología , Receptores CCR2 , Receptores de Quimiocina/agonistas , Esporas Fúngicas/inmunología , Linfocitos T/inmunología , Linfocitos T/patología , Factores de TiempoRESUMEN
Lungkine (CXCL15) is a novel CXC chemokine that is highly expressed in the adult mouse lung. To determine the biologic function of Lungkine, we generated Lungkine null mice by targeted gene disruption. These mice did not differ from wild-type mice in their hematocrits or in the relative number of cells in leukocyte populations of peripheral blood or other tissues, including lung and bone marrow. However, Lungkine null mice were more susceptible to Klebsiella pneumonia infection, with a decreased survival and increased lung bacterial burden compared with infected wild-type mice. Histologic analysis of the lung and assessment of leukocytes in the bronchioalveolar lavage revealed that neutrophil numbers were normal in the lung parenchyma, but reduced in the airspace. The production of other neutrophil chemoattractants in the Lungkine null mice did not differ from that in wild-type mice, and neutrophil migration into other tissues was normal. Taken together, these findings demonstrate that Lungkine is an important mediator of neutrophil migration from the lung parenchyma into the airspace.